A new feasibility evaluation of a Continuous Positive Airway Pressure (CPAP) device has been announced by the University of Utah and Dynasthetics LLC. This clinical trial, scheduled to begin recruitment, aims to explore the potential of the device in volunteer settings. Regulatory and clinical teams should prepare for possible updates as this study unfolds.
What are the study details?
This study, titled “Positive Airway Pressure (PAP) System Evaluation in Volunteers,” is designed to evaluate the feasibility of a CPAP device in a controlled volunteer setting. The trial, listed under ClinicalTrials.gov identifier NCT07246538, is not yet recruiting participants at the time of reporting.
The sponsors include the University of Utah, a reputable institution known for medical research, and Dynasthetics LLC, a medical device company specializing in innovative solutions. The collaboration aims to identify the clinical feasibility of the device under evaluation. Recruitment status, updated timelines, and further details can be tracked through the provided ClinicalTrials.gov link.
What is the purpose of the CPAP device?
CPAP devices are designed to maintain an open airway in individuals with breathing difficulties, commonly used to treat obstructive sleep apnea. This evaluation seeks to affirm the intended purpose in broader applications while gathering usability data from voluntary participants. Advancing technology in PAP systems may lead to improved user compliance and therapeutic efficacy.
The device’s role prioritizes consistent airflow to prevent airway collapse, aiming to improve patient outcomes. Research like this is significant for device optimization and regulatory submissions.
How will safety and performance be assessed?
The clinical trial will focus on safety and performance as outlined in Medical Device Regulation (MDR) Annex XIV. Volunteers will interact with the CPAP device to assess various parameters, including comfort, reliability, and functionality. These metrics aim to provide quantitative and qualitative data critical for determining feasibility, safety, and long-term clinical outcomes.
Both sponsors will likely document adverse events meticulously and adhere to Good Clinical Practices (GCP). Completion of the evaluation could influence future design considerations or amendments to regulatory filings.
FAQ
-
What is the recruitment timeline?
The study is listed as “Not yet recruiting.” Recruitment timelines will be updated on ClinicalTrials.gov.
-
Can the general public participate?
Participation criteria will be detailed in the study’s recruitment phase. Check the ClinicalTrials.gov link for updates.
-
What are the sponsorship roles?
The University of Utah oversees trial operations, while Dynasthetics LLC contributes device expertise and development insights.
Conclusion
The Positive Airway Pressure system feasibility study represents a meaningful step in medical device innovation. Regulatory and clinical professionals should keep track of this study as its findings may influence future CPAP device usage recommendations.
Disclaimer
This content is intended for informational purposes. It does not constitute legal advice on medical device regulation, clinical trials, or clearance procedures.
Announcement Link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07246538?term=medical+device